Macular edema - PDFSEARCH.IO - Document Search Engine

Macular edema
Results: 201

#	Item
21	SightLine Fall 2010 The Wilmer Eye Institute at Johns Hopkins Potential Add to Reading List Source URL: www.hopkinsmedicine.org Language: English Blindness Macular degeneration Research to Prevent Blindness Diabetic retinopathy Eye disease Biomedical engineering Macular edema National Institutes of Health Retina Ophthalmology Health Medicine
22	Supplement to March 2015 Ranibizumab: Expanding Add to Reading List Source URL: retinatoday.com Language: English - Date: 2015-03-11 17:23:00 Blindness Ranibizumab Vascular endothelial growth factor Macular edema Central retinal vein occlusion Ocular ischemic syndrome Glaucoma Macula of retina Central retinal vein Ophthalmology Medicine Health
23	VI Supplement to MarchEW Add to Reading List Source URL: www.retinatoday.com Language: English - Date: 2015-03-10 15:04:01 Angiology Vascular endothelial growth factor Ranibizumab Diabetic retinopathy Bevacizumab Macular edema Macular degeneration Laser coagulation Retina Medicine Ophthalmology Vision
24	RANZCO 2014 46th Annual Scientific Congress – POSTERS PROGRAM POSTER 1 PRESENTER Dr Warren Apel Add to Reading List Source URL: ranzco2014.com.au Language: English - Date: 2014-11-18 22:46:56 Blindness Glaucoma Cataract surgery Vascular endothelial growth factor Macular degeneration Ranibizumab Bevacizumab Cataract Macular edema Medicine Ophthalmology Health
25	6.2 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial, 4 mg/0.1 mL injection, 1 x 0.09 mL syringe; Eylea®; Bayer Australia Ltd. Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Ranibizumab Vascular endothelial growth factor Bevacizumab Macular degeneration Macular edema Diabetic retinopathy Laser coagulation Retina Low vision Medicine Ophthalmology Vision
26	Public Summary Document – November 2014 PBAC Meeting 7.1 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial, Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Ranibizumab Vascular endothelial growth factor Bevacizumab Macular edema Central retinal vein occlusion Macular degeneration Diabetic retinopathy Macula of retina Central retinal vein Ophthalmology Medicine Health
27	7.1 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial, 4 mg/0.1 mL injection, 1 x 0.09 mL syringe; Eylea®; Bayer Australia Ltd. Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Ranibizumab Bevacizumab Vascular endothelial growth factor Macular degeneration Macular edema Pharmaceutical Benefits Scheme Central retinal vein occlusion Off-label use Macula of retina Medicine Ophthalmology Health
28	Public Summary Document – November 2014 PBAC Meeting 6.2 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial, Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Ranibizumab Vascular endothelial growth factor Bevacizumab Macular degeneration Macular edema Diabetic retinopathy Laser coagulation Off-label use Retina Medicine Ophthalmology Health
29	Tissue-Sparing Photocoagulation Bibliography Retina: Clinical Diabetic Retinopathy: Diabetic Macular Edema Articles 1. Friberg TR, Karatza EC. The treatment of macular disease using a micropulsed and continuous Add to Reading List Source URL: salientmed.com Language: English - Date: 2013-11-26 12:12:14 Laser medicine Blindness Diabetes Laser coagulation Macular edema Diabetic retinopathy Central serous retinopathy Nd:YAG laser Glaucoma Medicine Ophthalmology Optics
30	RETINA surgery FEATURE STORY Guiding “Invisible” Laser Treatment Optical coherence tomography and fluorescein angiography imaging may be combined with a pattern scanning delivery device to optimize micropulse laser Add to Reading List Source URL: salientmed.com Language: English - Date: 2014-09-19 14:33:05 Blindness Diabetic retinopathy Laser medicine Central serous retinopathy Macular edema Laser coagulation Retina Vitreous hemorrhage Floater Ophthalmology Health Diabetes